菲律宾宿务单剂次登革热疫苗大规模接种效果:病例对照研究
共纳入490例病例和980名对照,结果显示单剂疫苗对伴有警告症状的登革热有51%保护力,但对总体住院登革热的保护力为26%且未达统计学显著性。
要点
- 单剂疫苗对总体住院病毒学确诊登革热的保护力为26%(95%CI -2-47%),无统计学意义。
- 社区为基础的单剂次大规模接种可提供对伴有警告症状登革热的保护。
研究设计与样本
- 共纳入490例病例和980名对照。
临床怎么用
- 对 milder 疾病的保护效果尚不明确,需结合当地流行病学与疫苗供应策略综合评估。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dengue fever is an important public health problem in the Philippines. In April 2016, the Department of Health launched a three-dose school based dengue vaccination program of nine- to fourteen-year-old children in three regions with the highest number of dengue cases using CYD-TDV (Dengvaxia, Sanofi Pasteur). In July 2017, a community-based dengue vaccination program was implemented in Cebu province. The program was discontinued in December 2017 amidst public controversy, after the first dose had been administered. We assessed the effectiveness of a single dose of CYD-TDV against hospitalized virologically confirmed dengue (VCD). METHODS: We conducted a case-control study in Cebu province following the dengue mass vaccination. Children who were nine to fourteen years of age during the mass vaccination and subsequently admitted to any of four participating public hospitals with suspected dengue were enrolled in the study as cases. Blood for RT-PCR and clinical and socio-demographic information were obtained. To estimate the level of vaccine protection, vaccination status was compared between children with hospitalized virologically confirmed dengue and controls of the same six-year age-group as the cases, matched on sex, neighborhood and time of occurrence of cases. FINDINGS: We enrolled 490 cases and 980 controls. Receipt of one dose of CYD-TDV was associated with 26% (95 % CI, -2 to 47%; p = 0 0675) overall protection against hospitalized virologically confirmed dengue and 51% (95 % CI, 23 to 68; p = 0 0016) protection against dengue with warning signs. INTERPRETATION: A single dose of CYD-TDV given to nine to fourteen-year-old children through a community-based mass vaccination program conferred protection against dengue with warning signs and severe dengue but we were unable to conclude on protection against milder illness.
引用
- Ylade M, Agrupis KA, Daag JV, et al. Effectiveness of a single-dose mass dengue vaccination in Cebu, Philippines: A case-control study. Vaccine. 2021. PMID: 34373121. doi:10.1016/j.vaccine.2021.07.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。